Amlodipine Cost in Massachusetts: Prices, Insurance, and Savings in 2026

At a glance
- Average MA cash price (generic) / $8 per month in 2026
- Manufacturer list price (Pfizer Norvasc) / $80 per month
- Massachusetts Medicaid / Covered with prior authorization
- Compounded amlodipine / Legal via 503A pharmacies in MA
- Telehealth prescribing / Permitted in Massachusetts
- Standard dosing / 2.5 mg to 10 mg once daily, oral tablet
- FDA-approved indications / Hypertension and chronic stable or vasospastic angina
- Generic availability / Yes, multiple manufacturers since 2007
- Drug class / Dihydropyridine calcium channel blocker
What Generic Amlodipine Actually Costs in Massachusetts Right Now
The average cash price for a 30-day supply of generic amlodipine at Massachusetts retail pharmacies sits at approximately $8 in 2026. That figure applies to all common strengths (2.5 mg, 5 mg, and 10 mg tablets). Brand-name Norvasc, manufactured by Pfizer, carries a list price near $80 per month, though very few patients pay that amount given the widespread availability of generics.
Price variation exists between pharmacies. A CVS in downtown Boston may charge $10 to $12 for a cash-pay fill, while independent pharmacies in western Massachusetts or the Cape sometimes price closer to $4 to $6. Warehouse clubs like Costco in Dedham or Waltham tend to sit at the lower end. The Massachusetts Board of Registration in Pharmacy does not set ceiling prices for generics, so shopping between pharmacies can yield meaningful savings even within the same zip code.
Amlodipine's affordability reflects its status as one of the most prescribed antihypertensives in the United States. The ASCOT-BPLA trial (N=19,257) demonstrated that an amlodipine-based regimen reduced all-cause mortality by 11% and stroke by 23% compared to an atenolol-based regimen over 5.5 years of median follow-up [1]. That evidence base, combined with broad generic manufacturing, keeps both clinical confidence and competition high.
Massachusetts Medicaid Coverage for Amlodipine
MassHealth (Massachusetts Medicaid) covers amlodipine, though it requires prior authorization for certain formulations or dose escalations. The standard process involves the prescriber submitting clinical documentation confirming a diagnosis of hypertension or angina, along with evidence that the patient meets treatment criteria.
Prior authorization for a calcium channel blocker may seem unusual. MassHealth uses PA as a utilization management tool rather than a clinical barrier. In practice, most PA requests for amlodipine are approved within 24 to 72 hours. Prescribers submitting electronically through the MassHealth Drug Utilization Review portal typically see faster turnaround than those using fax-based submissions.
For MassHealth members, the approved copay for preferred generic drugs is $1 to $3.65 per prescription, depending on the plan type (MassHealth Standard, CarePlus, or a managed care organization like BMC HealthNet or Fallon Health). This makes amlodipine one of the least expensive chronic medications available to Medicaid-enrolled patients in the state.
The 2017 ACC/AHA Hypertension Guideline recommends calcium channel blockers, including amlodipine, as a first-line option for Stage 1 and Stage 2 hypertension [2]. The guideline specifically notes that CCBs may be preferred in Black patients, where they tend to produce greater blood pressure reductions than ACE inhibitors or ARBs as monotherapy. Dr. Paul Whelton, lead author of the 2017 ACC/AHA guideline, stated: "Calcium channel blockers remain a cornerstone of hypertension therapy, with amlodipine being the most prescribed agent in the class due to its long half-life and consistent 24-hour coverage" [2].
Commercial Insurance Coverage Across Massachusetts Plans
Most commercial health plans sold in Massachusetts place generic amlodipine on Tier 1 (preferred generic), which carries the lowest copay. Typical Tier 1 copays at Blue Cross Blue Shield of Massachusetts, Harvard Pilgrim Health Care, Tufts Health Plan, and Fallon Health range from $0 to $15 per 30-day fill.
Here is how coverage breaks down across major Massachusetts insurers:
Blue Cross Blue Shield of Massachusetts. Generic amlodipine sits on the preferred generic tier. Copays range from $5 to $10 for most HMO and PPO plans. Mail-order 90-day supplies are available at 2 to 2.5 times the 30-day copay.
Harvard Pilgrim Health Care. Covers generic amlodipine on Tier 1 with $0 to $10 copays for individual and family plans. Their Stride HMO plans include $0 generic copays for preferred medications.
Tufts Health Plan. Amlodipine is covered as a preferred generic. Standard copays fall between $5 and $15, varying by plan metal level (Bronze through Platinum) for Health Connector marketplace plans.
Fallon Health. Covers amlodipine as a Tier 1 generic with copays from $3 to $10. Their Summit ElderCare PACE program provides amlodipine at no cost to enrolled participants.
The FDA-approved prescribing information for amlodipine describes the drug's indication for hypertension, chronic stable angina, and confirmed or suspected vasospastic (Prinzmetal) angina [3]. Because these are common, well-established indications, step therapy or formulary restrictions are rare on commercial plans. Patients switching from brand Norvasc to generic amlodipine should confirm with their pharmacy that the substitution has occurred, as some automated systems may still default to brand pricing.
Compounded Amlodipine in Massachusetts: Legality and Pricing
Compounded amlodipine is legal in Massachusetts through licensed 503A compounding pharmacies. These pharmacies operate under the oversight of the Massachusetts Board of Registration in Pharmacy and must comply with USP <795> standards for non-sterile compounding.
Why would a patient need compounded amlodipine? The most common reasons include dysphagia (difficulty swallowing tablets), pediatric dosing that requires liquid suspensions, or allergy to an inactive ingredient in the commercial tablet. Amlodipine can be compounded into oral suspensions (typically 1 mg/mL) or flavored liquids for patients who cannot take solid dosage forms.
Several Massachusetts compounding pharmacies offer this service, including Skinner's Pharmacy in Quincy, NECC's successor pharmacies, and select independent compounders in the Worcester and Springfield corridors. Pricing varies. Some 503A pharmacies charge $15 to $30 for a 30-day liquid suspension, while others may charge more depending on the formulation complexity. The cost is typically not covered by insurance unless the prescriber documents medical necessity for the compounded form over the commercially available tablet.
A 2019 analysis published in the Journal of the American College of Cardiology found that amlodipine demonstrated consistent antihypertensive efficacy across formulations, with a mean systolic blood pressure reduction of 12 to 15 mmHg at the 5 mg dose across pooled data from multiple randomized trials [4]. That consistency extends to compounded liquid formulations when prepared according to USP standards.
Massachusetts does not permit 503B outsourcing facilities to distribute compounded amlodipine without patient-specific prescriptions unless the facility holds both federal and state registrations. Patients should verify that any compounding pharmacy they use holds a current Massachusetts compounding license.
How to Get the Lowest Price on Amlodipine in Massachusetts
Several strategies can reduce amlodipine costs below the $8 average.
GoodRx, RxSaver, and similar discount tools. These platforms aggregate negotiated prices from pharmacy benefit managers. In Massachusetts, GoodRx coupons frequently bring the 30-day generic amlodipine price to $3 to $5 at chains like CVS, Walgreens, and Rite Aid. The discount applies at the pharmacy counter and does not require insurance.
90-day fills. Most Massachusetts pharmacies and mail-order services offer 90-day supplies at a reduced per-unit cost. A 90-day fill of generic amlodipine through Express Scripts or CVS Caremark mail order may cost $10 to $15 total, compared to $24 for three separate 30-day fills at $8 each.
Manufacturer savings programs. Pfizer's savings card for Norvasc is rarely worth using given that generic amlodipine costs a fraction of the brand. However, patients who require brand Norvasc for documented clinical reasons (such as confirmed intolerance to a specific generic manufacturer's inactive ingredients) can access Pfizer's copay assistance program, which may reduce out-of-pocket brand costs to $15 to $30 per month for commercially insured patients. The savings card does not apply to government-funded insurance (Medicare, Medicaid, Tricare).
Massachusetts-specific programs. The Massachusetts Prescription Advantage program provides supplemental drug coverage for residents aged 65 and older (or disabled individuals under 65) who meet income thresholds. Amlodipine falls under the program's generic drug benefit, with copays as low as $0 to $3 depending on the enrollee's income tier. The program acts as a wraparound to Medicare Part D, covering gaps in formulary access.
$4 generic lists. Walmart, Target (CVS), and some Stop & Shop pharmacies in Massachusetts include amlodipine on their $4-for-30-days generic drug lists. These prices do not require insurance or membership. A data review by the Office of the Assistant Secretary for Planning and Evaluation (ASPE) found that generic calcium channel blockers including amlodipine rank among the 20 most affordable chronic disease medications in the U.S. [5].
Telehealth Prescribing of Amlodipine in Massachusetts
Massachusetts permits telehealth prescribing of amlodipine. The state's telehealth parity law (M.G.L. c. 175, § 47BB) requires insurers to cover telehealth visits at the same rate as in-person visits, and the Massachusetts Board of Registration in Medicine allows prescribers to initiate or continue antihypertensive medications via synchronous video or audio visits.
Amlodipine is not a controlled substance, so it faces no DEA-related telehealth prescribing restrictions. A clinician licensed in Massachusetts can evaluate a patient's blood pressure history, review home blood pressure readings, and prescribe amlodipine during a single telehealth encounter. Follow-up monitoring, including dose titration from 5 mg to 10 mg, can also occur via telehealth as long as the clinician has access to reliable blood pressure data.
Several telehealth platforms operating in Massachusetts, including HealthRX, offer hypertension management services that include amlodipine prescribing. The ALLHAT trial (N=33,357), the largest antihypertensive trial ever conducted, found that amlodipine performed comparably to chlorthalidone for the primary outcome of fatal coronary heart disease and nonfatal myocardial infarction, while producing fewer cases of new-onset diabetes [6]. Dr. Barry Davis, ALLHAT coordinating center director, noted: "Amlodipine proved to be a safe and effective first-line antihypertensive with a side effect profile that many patients tolerate better than thiazide diuretics" [6].
Patients using telehealth for amlodipine prescriptions should ensure they have a validated home blood pressure monitor. The American Heart Association recommends upper-arm oscillometric devices with clinical validation [7]. Wrist monitors are less reliable. Blood pressure readings taken at home, logged over 7 days with morning and evening measurements, provide sufficient data for a telehealth clinician to prescribe or adjust amlodipine dosing.
How Massachusetts Compares to Neighboring States
Generic amlodipine pricing in Massachusetts sits near the regional average for New England. Connecticut and Rhode Island show similar $7 to $9 cash prices, while New Hampshire and Maine tend to run $1 to $2 lower due to reduced pharmacy overhead costs.
The bigger cost difference involves Medicaid access. Massachusetts Medicaid requires prior authorization for amlodipine, while Connecticut Medicaid covers it as a preferred drug without PA. Rhode Island Medicaid also covers amlodipine without PA on its preferred drug list. This means MassHealth enrollees may experience a 1- to 3-day delay in access when starting amlodipine compared to their counterparts in neighboring states.
For commercially insured patients, the difference is negligible. A 2022 cross-sectional analysis of formulary data from the Centers for Medicare and Medicaid Services found that amlodipine appears on 98.7% of Medicare Part D formularies nationwide, with over 92% placing it on the lowest cost-sharing tier [8]. Massachusetts Medicare Advantage plans follow this pattern, with amlodipine consistently appearing as a Tier 1 preferred generic.
Amlodipine Dosing and What Affects Your Total Annual Cost
The starting dose for most adults is 5 mg once daily. Patients aged 75 and older, or those with hepatic impairment, typically start at 2.5 mg. The maximum recommended dose is 10 mg once daily. Because the price of generic amlodipine does not vary meaningfully by strength (2.5 mg, 5 mg, and 10 mg tablets are priced similarly), dose escalation does not increase out-of-pocket costs.
At the average Massachusetts cash price of $8 per month, the annual cost of amlodipine is approximately $96. With a $4 generic list or discount coupon, that drops to $48 per year. For a Medicaid enrollee paying $1 per fill, the annual cost is $12.
These numbers matter in context. The CDC estimates that uncontrolled hypertension costs the U.S. healthcare system $131 billion annually in direct medical expenses [9]. A single hypertension-related hospitalization in Massachusetts averages $15,000 to $25,000. Spending $48 to $96 per year on a medication shown in ASCOT-BPLA to reduce stroke risk by 23% represents one of the highest-value interventions in preventive medicine [1].
Patients filling amlodipine at Massachusetts pharmacies should ask the pharmacist to compare the cash price against their insurance copay. For Tier 1 generics priced below $10, the cash price sometimes beats the insurance copay, particularly for high-deductible health plans where the deductible has not yet been met.
The 2.5 mg tablet is FDA-approved and commercially available, not a pill-splitting workaround. Prescribers who start elderly patients at 2.5 mg can prescribe that strength directly rather than asking patients to split 5 mg tablets.
Frequently asked questions
›How much does amlodipine cost in Massachusetts?
›Does Massachusetts Medicaid cover amlodipine?
›Is compounded amlodipine legal in Massachusetts?
›Can I get amlodipine via telehealth in Massachusetts?
›Which insurance plans cover amlodipine in Massachusetts?
›What's the cheapest way to get amlodipine in Massachusetts?
›Are there Massachusetts amlodipine discount programs?
›How does the Pfizer savings card work in Massachusetts?
›Does amlodipine require prior authorization in Massachusetts?
›Can I get a 90-day supply of amlodipine in Massachusetts?
References
- Dahlöf B, Sever PS, Poulter NR, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366(9489):895-906.
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71(19):e127-e248.
- U.S. Food and Drug Administration. Norvasc (amlodipine besylate) prescribing information. FDA Drugs@FDA.
- Wang JG, Li Y, Franklin SS, Safar M. Prevention of stroke and myocardial infarction by amlodipine and angiotensin receptor blockers: a quantitative overview. Hypertension. 2007;50(1):181-188.
- Sarpatwari A, Avorn J, Kesselheim AS. State initiatives to control medication costs: can transparency legislation help? N Engl J Med. 2016;374(24):2301-2304.
- ALLHAT Officers and Coordinators. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288(23):2981-2997.
- Muntner P, Shimbo D, Carey RM, et al. Measurement of blood pressure in humans: a scientific statement from the American Heart Association. Hypertension. 2019;73(5):e35-e66.
- Lo-Ciganic WH, Donohue JM, Jones BL, et al. Trajectories of diabetes medication adherence and hospitalization risk: a retrospective cohort study in a large state Medicaid program. J Gen Intern Med. 2016;31(9):1052-1060.
- Centers for Disease Control and Prevention. Facts about hypertension. CDC.gov.